|
Name |
(1S,5R,6R,14R,15S,17R,22S)-5,10,15-trihydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.03,12.04,9.017,22]docosa-3(12),4(9),10,20-tetraene-8,19-dione
|
Molecular Formula | C25H30O7 | |
IUPAC Name* |
(1S,5R,6R,14R,15S,17R,22S)-5,10,15-trihydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.03,12.04,9.017,22]docosa-3(12),4(9),10,20-tetraene-8,19-dione
|
|
SMILES |
C[C@@H]1[C@@H](C2=C(C(=CC3=C2C[C@H]4[C@]5(C=CC(=O)C([C@@H]5C[C@@H]([C@@]4(O3)C)O)(C)C)C)O)C(=O)O1)O
|
|
InChI |
InChI=1S/C25H30O7/c1-11-21(29)19-12-8-16-24(4)7-6-17(27)23(2,3)15(24)10-18(28)25(16,5)32-14(12)9-13(26)20(19)22(30)31-11/h6-7,9,11,15-16,18,21,26,28-29H,8,10H2,1-5H3/t11-,15+,16+,18+,21+,24+,25-/m1/s1
|
|
InChIKey |
KCLJXKIILUZVBN-WREWNJFMSA-N
|
|
Synonyms |
CHEMBL3581315; CHEBI:156418; DTXSID401099581; BDBM50107845; 132196-53-3; 2H,4H-Benzo[a]pyrano[3,4-j]xanthene-4,11(7aH)-dione, 1,8,9,9a,10,13a,13b,14-octahydro-1,5,8-trihydroxy-2,7a,10,10,13a-pentamethyl-, (1R,2R,7aR,8S,9aR,13aS,13bS)-
|
|
CAS | 132196-53-3 | |
PubChem CID | 101565497 | |
ChEMBL ID | CHEMBL3581315 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 442.5 | ALogp: | 3.2 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 113.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 32 | QED Weighted: | 0.526 |
Caco-2 Permeability: | -5.2 | MDCK Permeability: | 0.00001390 |
Pgp-inhibitor: | 0.268 | Pgp-substrate: | 0.709 |
Human Intestinal Absorption (HIA): | 0.05 | 20% Bioavailability (F20%): | 0.028 |
30% Bioavailability (F30%): | 0.176 |
Blood-Brain-Barrier Penetration (BBB): | 0.705 | Plasma Protein Binding (PPB): | 85.81% |
Volume Distribution (VD): | 0.891 | Fu: | 9.99% |
CYP1A2-inhibitor: | 0.059 | CYP1A2-substrate: | 0.44 |
CYP2C19-inhibitor: | 0.023 | CYP2C19-substrate: | 0.593 |
CYP2C9-inhibitor: | 0.087 | CYP2C9-substrate: | 0.58 |
CYP2D6-inhibitor: | 0.271 | CYP2D6-substrate: | 0.099 |
CYP3A4-inhibitor: | 0.639 | CYP3A4-substrate: | 0.596 |
Clearance (CL): | 9.499 | Half-life (T1/2): | 0.231 |
hERG Blockers: | 0.729 | Human Hepatotoxicity (H-HT): | 0.61 |
Drug-inuced Liver Injury (DILI): | 0.184 | AMES Toxicity: | 0.048 |
Rat Oral Acute Toxicity: | 0.879 | Maximum Recommended Daily Dose: | 0.962 |
Skin Sensitization: | 0.167 | Carcinogencity: | 0.33 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.959 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003163 | 0.800 | D02QJH | 0.255 | ||||
ENC002386 | 0.593 | D02JNM | 0.254 | ||||
ENC002748 | 0.336 | D0D2TN | 0.252 | ||||
ENC002749 | 0.336 | D0W2EK | 0.250 | ||||
ENC003225 | 0.326 | D0F1EX | 0.248 | ||||
ENC005567 | 0.326 | D0P0HT | 0.244 | ||||
ENC005535 | 0.326 | D01XWG | 0.243 | ||||
ENC005568 | 0.326 | D01XDL | 0.243 | ||||
ENC004881 | 0.326 | D08PIQ | 0.242 | ||||
ENC004880 | 0.326 | D0CZ1Q | 0.242 |